For: | Bradford K, Shih DQ. Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease. World J Gastroenterol 2011; 17(37): 4166-4173 [PMID: 22072847 DOI: 10.3748/wjg.v17.i37.4166] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i37/4166.htm |
Number | Citing Articles |
1 |
Stephen Balevic, Catherine A Sims, Amanda Eudy, Valerie Smith, Megan Clowse. Azathioprine metabolite levels and outcomes during pregnancies with rheumatic disease. Lupus Science & Medicine 2024; 11(1): e001036 doi: 10.1136/lupus-2023-001036
|
2 |
Hilal Ahmad, Vijay L. Kumar. Pharmacotherapy of ulcerative colitis – current status and emerging trends. Journal of Basic and Clinical Physiology and Pharmacology 2018; 29(6): 581 doi: 10.1515/jbcpp-2016-0014
|
3 |
Hiromu Morikubo, Taku Kobayashi, Ryo Ozaki, Shinji Okabayashi, Satoshi Kuronuma, Osamu Takeuchi, Tenyo Shiba, Hiroki Kiyohara, Mao Matsubayashi, Shintaro Sagami, Masaru Nakano, Osamu Ikezaki, Tadakazu Hisamatsu, Yoichi Tanaka, Toshifumi Hibi. Differential effects of mesalazine formulations on thiopurine metabolism through thiopurine S‐methyltransferase inhibition. Journal of Gastroenterology and Hepatology 2021; 36(8): 2116 doi: 10.1111/jgh.15411
|
4 |
Shinichiro Shinzaki, Kayoko Sakagami, Miki Matsumoto, Tetsuo Takehara, Hiroaki Ito. Nurse-Provided Medication Guidance for Improving Drug Adherence to Thiopurines in Outpatients With Inflammatory Bowel Disease: A Single-Center Prospective Study. Crohn's & Colitis 360 2022; 4(1) doi: 10.1093/crocol/otab081
|
5 |
Stine N. Nielsen, Thomas L. Frandsen, Jacob Nersting, Lisa L. Hjalgrim, Kjeld Schmiegelow. Pharmacokinetics of 6-Thioguanine and 6-Mercaptopurine Combination Maintenance Therapy of Childhood ALL. Journal of Pediatric Hematology/Oncology 2015; 37(3): e206 doi: 10.1097/MPH.0000000000000246
|
6 |
Sofia Pagarin, Anna Bolognese, Stefano Fornasaro, Martina Franzin, Ute Hofmann, Marianna Lucafò, Raffaella Franca, Matthias Schwab, Gabriele Stocco, Giuliana Decorti, Alois Bonifacio. SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells. Chemico-Biological Interactions 2024; 387: 110792 doi: 10.1016/j.cbi.2023.110792
|
7 |
Marina Millán, Manuel Castro-Fernández, Javier Ampuero, Manuel Romero-Gómez. Mielotoxicidad por la interacción entre azatioprina y alopurinol en paciente con enfermedad de Crohn. Gastroenterología y Hepatología 2013; 36(4): 298 doi: 10.1016/j.gastrohep.2012.10.002
|
8 |
N. M. Heerasing, J. F. Ng, D. Dowling. Does lymphopenia or macrocytosis reflect 6‐thioguanine levels in patients with inflammatory bowel disease treated with azathioprine or 6‐mercaptopurine?. Internal Medicine Journal 2016; 46(4): 465 doi: 10.1111/imj.12915
|
9 |
Al-Abbassi Lahib Mohammed, Sharba Intisar Razzaq, Al-Hatemy Kareem Talib. The protective efficacy of Aloe vera gel against leukopenia and thrombocytopenia caused by (methotrexate and azathioprine) drugs. PHYSICAL MESOMECHANICS OF CONDENSED MATTER: Physical Principles of Multiscale Structure Formation and the Mechanisms of Nonlinear Behavior: MESO2022 2023; 2899: 020006 doi: 10.1063/5.0157100
|
10 |
Aline Correa Ribeiro, Luciane Henriques Furtado Barroso, Carlos Alberto Mourao-Junior, Julio Maria Fonseca Chebli, Jorge Willian Leandro Nascimento. Simultaneous Monitoring of Azathioprine Metabolites in Erythrocytes of Crohn’s Disease Patients by HPLC-UV. Journal of Chromatographic Science 2022; 60(6): 518 doi: 10.1093/chromsci/bmab084
|
11 |
Jan Kneusels, Meike Kaehler, Ingolf Cascorbi, Thilo Wedel, Michel Neunlist, Ralph Lucius, François Cossais. Limited Impact of 6-Mercaptopurine on Inflammation-Induced Chemokines Expression Profile in Primary Cultures of Enteric Nervous System. Neurochemical Research 2021; 46(7): 1781 doi: 10.1007/s11064-021-03324-y
|
12 |
Rachele Ciccocioppo, Caterina Mengoli, Elena Betti, Giuditta Comolli, Irene Cassaniti, Antonio Piralla, Peter Kruzliak, Martin Caprnda, Lodovica Pozzi, Gino Roberto Corazza, Antonio Di Sabatino, Fausto Baldanti. Human Cytomegalovirus and Epstein-Barr virus specific immunity in patients with ulcerative colitis. Clinical and Experimental Medicine 2021; 21(3): 379 doi: 10.1007/s10238-021-00702-2
|
13 |
Saba Hasan, Prankur Awasthi, Sumira Malik, Manish Dwivedi. Immunotherapeutic strategies to induce inflection in the immune response: therapy for cancer and COVID-19. Biotechnology and Genetic Engineering Reviews 2024; 40(4): 3571 doi: 10.1080/02648725.2022.2147661
|
14 |
Marco Vincenzo Lenti, Christian P. Selinger. Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions. Expert Review of Gastroenterology & Hepatology 2017; : 1 doi: 10.1080/17474124.2017.1284587
|
15 |
Ewa Dudzińska, Aneta Strachecka, Paulina Gil-Kulik, Janusz Kocki, Jacek Bogucki, Natalya Shemedyuk, Magdalena Gryzinska. Influence of the Treatment Used in Inflammatory Bowel Disease on the Protease Activities. International Journal of General Medicine 2020; : 1633 doi: 10.2147/IJGM.S267036
|
16 |
Daniel Rehling, Si Min Zhang, Ann-Sofie Jemth, Tobias Koolmeister, Adam Throup, Olov Wallner, Emma Scaletti, Takaya Moriyama, Rina Nishii, Jonathan Davies, Matthieu Desroses, Sean G. Rudd, Martin Scobie, Evert Homan, Ulrika Warpman Berglund, Jun J. Yang, Thomas Helleday, Pål Stenmark. Crystal structures of NUDT15 variants enabled by a potent inhibitor reveal the structural basis for thiopurine sensitivity. Journal of Biological Chemistry 2021; 296: 100568 doi: 10.1016/j.jbc.2021.100568
|
17 |
Mehrab Pourmadadi, Arsalan Rahmani Ghohrodi, Zeinab Savari, Ehsan Talebi, Iman Ahamdi, Abbas Rahdar, Sadanand Pandey. Enhancing cancer therapy: The potential of mercaptopurine-based nanomaterials for targeted drug delivery. Next Nanotechnology 2023; 2: 100018 doi: 10.1016/j.nxnano.2023.100018
|
18 |
Nicholas C.K. Valerie, Anna Hagenkort, Brent D.G. Page, Geoffrey Masuyer, Daniel Rehling, Megan Carter, Luka Bevc, Patrick Herr, Evert Homan, Nina G. Sheppard, Pål Stenmark, Ann-Sofie Jemth, Thomas Helleday. NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine. Cancer Research 2016; 76(18): 5501 doi: 10.1158/0008-5472.CAN-16-0584
|
19 |
Pegah Hosseini-Carroll, Monica Mutyala, Abhishek Seth, Shaheen Nageeb, Demiana Soliman, Moheb Boktor, Ankur Sheth, Jonathon Chapman, James Morris, Paul Jordan, Kenneth Manas, Felix Becker, Jonathan Steven Alexander. Pregnancy and inflammatory bowel diseases: Current perspectives, risks and patient management. World Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 156-171 doi: 10.4292/wjgpt.v6.i4.156
|
20 |
Karin Fetter, Markus Weigel, Benjamin Ott, Moritz Fritzenwanker, Sebastian Stricker, Jan de Laffolie, Torsten Hain. The microbiome landscape in pediatric Crohn’s disease and therapeutic implications. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2247019
|
21 |
Ahmad Yahyazadeh. Alteration of Sublingual Gland after Exposure to 6-Mercaptopurine in Male Rat: Potential Efficacy of Propolis. Meandros Medical And Dental Journal 2024; 25(1): 12 doi: 10.69601/meandrosmdj.1491717
|
22 |
Qingqing Cai, Li Zhang, Ling Li, Juan Tan, Shiyue Wu, Yi Wang, Wensheng Fu. Detection of Chemotherapeutic Drug 6-Mercaptopurine Through Manipulating Localized Surface Plasmon Resonance Absorption of Silver Nanoplates. Nano 2021; 16(04): 2150046 doi: 10.1142/S1793292021500466
|
23 |
Kimura Yutaka, Yasuno Rie, Tomoko Iwaki, Chizu Fujimura, Yoshihiro Ohmiya, Yoshihiro Nakajima, Takashi Omori, Emanuela Corsini, Tomoaki Inoue, Erwin L. Rogen, Hajime Kojima, Setsuya Aiba. An international validation study of the interleukin-2 luciferase leukocyte toxicity test (IL-2 Luc LTT) to evaluate potential immunosuppressive chemicals and its performance after use with the interleukin-2 luciferase assay (IL-2 Luc assay). Toxicology in Vitro 2023; 88: 105535 doi: 10.1016/j.tiv.2022.105535
|
24 |
Monica R. P. Rao, Isha Ghadge, Saurav Kulkarni, Ashwini R. Madgulkar. Plant Specialized Metabolites. Reference Series in Phytochemistry 2023; : 1 doi: 10.1007/978-3-031-30037-0_5-1
|
25 |
Angelo V. Marzano, Alessandro Borghi, Pier Luigi Meroni, Carlo Crosti, Massimo Cugno. Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy. Autoimmunity 2014; 47(3): 146 doi: 10.3109/08916934.2013.873414
|
26 |
Kathleen E. LaDuke, Sarah Ehling, John M. Cullen, Wolfgang Bäumer. Effects of azathioprine, 6-mercaptopurine, and 6-thioguanine on canine primary hepatocytes. American Journal of Veterinary Research 2015; 76(7): 649 doi: 10.2460/ajvr.76.7.649
|
27 |
D. Q. Shih, M. Nguyen, L. Zheng, P. Ibanez, L. Mei, L. Y. Kwan, K. Bradford, C. Ting, S. R. Targan, E. A. Vasiliauskas. Split‐dose administration of thiopurine drugs: a novel and effective strategy for managing preferential 6‐MMP metabolism. Alimentary Pharmacology & Therapeutics 2012; 36(5): 449 doi: 10.1111/j.1365-2036.2012.05206.x
|
28 |
Jan Philipp Weltzsch, Claudius F. Bartel, Moritz Waldmann, Thomas Renné, Stephanie Schulze, Benedetta Terziroli Beretta-Piccoli, Maria Papp, Ye H. Oo, Vincenzo Ronca, Marcial Sebode, Ansgar W. Lohse, Christoph Schramm, Johannes Hartl. Optimizing thiopurine therapy in autoimmune hepatitis: A multicenter study on monitoring metabolite profiles and co-therapy with allopurinol. Hepatology 2024; 80(5): 1026 doi: 10.1097/HEP.0000000000000940
|
29 |
Yoomi Park, Hyery Kim, Jung Yoon Choi, Sunmin Yun, Byung-Joo Min, Myung-Eui Seo, Ho Joon Im, Hyoung Jin Kang, Ju Han Kim. Star Allele-Based Haplotyping versus Gene-Wise Variant Burden Scoring for Predicting 6-Mercaptopurine Intolerance in Pediatric Acute Lymphoblastic Leukemia Patients. Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00654
|
30 |
Ji Hyeon Lee, Tae Jun Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Li-Hwa Choi, Hye In Woo, Soo-Youn Lee, Young-Ho Kim, John Green. Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn’s disease. PLOS ONE 2017; 12(12): e0188925 doi: 10.1371/journal.pone.0188925
|
31 |
Samantha L. Sanford, Griffin A. Welfer, Bret D. Freudenthal, Patricia L. Opresko. Mechanisms of telomerase inhibition by oxidized and therapeutic dNTPs. Nature Communications 2020; 11(1) doi: 10.1038/s41467-020-19115-y
|
32 |
Takato Maeda, Hirotake Sakuraba, Hiroto Hiraga, Shukuko Yoshida, Yoichi Kakuta, Hidezumi Kikuchi, Shogo Kawaguchi, Keisuke Hasui, Tetsuya Tatsuta, Daisuke Chinda, Tatsuya Mikami, Shinsaku Fukuda. Long-term efficacy and tolerability of dose-adjusted thiopurine treatment in maintaining remission in inflammatory bowel disease patients with NUDT15 heterozygosity. Intestinal Research 2022; 20(1): 90 doi: 10.5217/ir.2020.00133
|
33 |
Roslyn Kemp, Elliott Dunn, Michael Schultz. Immunomodulators in Inflammatory Bowel Disease: An Emerging Role for Biologic Agents. BioDrugs 2013; 27(6): 585 doi: 10.1007/s40259-013-0045-2
|
34 |
Lucy Croyle, Eric F. Morand. Optimizing the use of existing therapies in lupus. International Journal of Rheumatic Diseases 2015; 18(2): 129 doi: 10.1111/1756-185X.12551
|
35 |
Blake H. Bentley, Alexa E. Cecil, William C. Lippert. Atypical Intrahepatic Cholestasis of Pregnancy: A Red Herring. ACG Case Reports Journal 2024; 11(4): e01339 doi: 10.14309/crj.0000000000001339
|
36 |
Abdullah Al Maruf, Luke Wan, Peter J. O’Brien. Evaluation of Azathioprine-Induced Cytotoxicity in anIn VitroRat Hepatocyte System. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/379748
|
37 |
Nadim H Malibary, Mohammed A Ezzat, Ahmed M Mogharbel, Khalid A Kouzaba, Abdulaziz A Alkadi, Usama H Malki, Sultan M Gharib, Faisal M Altowairqi, Omar I Saadah, Mahmoud H Mosli. Factors Affecting Ulcerative Colitis Flare-Ups: Associations With Smoking Habits and Other Patient Characteristics. Cureus 2021; doi: 10.7759/cureus.19834
|
38 |
Rachele Ciccocioppo, Francesca Racca, Luigia Scudeller, Antonio Piralla, Pietro Formagnana, Lodovica Pozzi, Elena Betti, Alessandro Vanoli, Roberta Riboni, Peter Kruzliak, Fausto Baldanti, Gino Roberto Corazza. Differential cellular localization of Epstein–Barr virus and human cytomegalovirus in the colonic mucosa of patients with active or quiescent inflammatory bowel disease. Immunologic Research 2016; 64(1): 191 doi: 10.1007/s12026-015-8737-y
|
39 |
Melissa A. Smith, Paul Blaker, Anthony M. Marinaki, Simon H. Anderson, Peter M. Irving, Jeremy D. Sanderson. Optimising outcome on thiopurines in inflammatory bowel disease by co-prescription of allopurinol. Journal of Crohn's and Colitis 2012; 6(9): 905 doi: 10.1016/j.crohns.2012.02.007
|
40 |
U. Kopylov, D. Amre, Y. Theoret, C. Deslandres, E.G. Seidman. Thiopurine Metabolite Ratios for Monitoring Therapy in Pediatric Crohn Disease. Journal of Pediatric Gastroenterology and Nutrition 2014; 59(4): 511 doi: 10.1097/MPG.0000000000000455
|
41 |
Amlan Jyoti Ghosh, Sagar Sarkar, Supriyo Ghosh, Tilak Saha. Alternatives to Antibiotics. 2022; : 419 doi: 10.1007/978-981-19-1854-4_17
|
42 |
Yutaka Kimura, Hitoshi Terui, Chizu Fujimura, Ryo Amagai, Toshiya Takahashi, Setsuya Aiba. Optimization of the IL-2 Luc assay for immunosuppressive drugs: a novel in vitro immunotoxicity test with high sensitivity and predictivity. Archives of Toxicology 2021; 95(8): 2755 doi: 10.1007/s00204-021-03101-4
|
43 |
Karolina Kaźmierczak-Siedlecka, Nikola Bulman, Paweł Ulasiński, Bartosz Kamil Sobocki, Karol Połom, Luigi Marano, Leszek Kalinowski, Karolina Skonieczna-Żydecka. Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs – is it a new perspective for personalized treatment of cancer patients?. Gut Microbes 2023; 15(2) doi: 10.1080/19490976.2023.2281017
|
44 |
Dunja Urbančič, Flaka Pasha, Alenka Šmid, Irena Mlinarič-Raščan. Personalization of thiopurine therapy: Current recommendations and future perspectives. Acta Pharmaceutica 2024; 74(3): 355 doi: 10.2478/acph-2024-0030
|
45 |
Qiuyuan Liu, Yanyan Wang, Qiao Mei, Wei Han, Jing Hu, Naizhong Hu. Measurement of red blood cell 6-thioguanine nucleotide is beneficial in azathioprine maintenance therapy of Chinese Crohn’s disease patients. Scandinavian Journal of Gastroenterology 2016; 51(9): 1093 doi: 10.3109/00365521.2016.1161068
|
46 |
Xin-Hui Khoo, Shin Yee Wong, Nik Razima Wan Ibrahim, Ruey Terng Ng, Kee Seang Chew, Way Seah Lee, Zhi Qin Wong, Raja Affend Raja Ali, Shahreedhan Shahrani, Alex Hwong-Ruey Leow, Ida Normiha Hilmi. Nudix Hydroxylase 15 Mutations Strongly Predict Thiopurine-Induced Leukopenia Across Different Asian Ethnicities: Implications for Screening in a Diverse Population. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.880937
|
47 |
Ingrid Fricke-Galindo, Helgi Jung-Cook, Adrián LLerena, Marisol López-López. Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics). Drug Metabolism and Personalized Therapy 2016; 31(2): 61 doi: 10.1515/dmpt-2015-0030
|
48 |
O. V. Khlynova, E. A. Stepina. Disturbance of intestinal permeability and its role in the development of cardiovascular complications in persons with inflammatory bowel diseases. Experimental and Clinical Gastroenterology 2023; (11): 36 doi: 10.31146/1682-8658-ecg-207-11-36-45
|
49 |
Lena S. Candels, Mussarat N. Rahim, Sital Shah, Michael A. Heneghan. Towards personalised medicine in autoimmune hepatitis: Measurement of thiopurine metabolites results in higher biochemical response rates. Journal of Hepatology 2021; 75(2): 324 doi: 10.1016/j.jhep.2021.03.023
|
50 |
Hartmut Kirchherr, Maria Shipkova, Nicolas von Ahsen. Improved Method for Therapeutic Drug Monitoring of 6-Thioguanine Nucleotides and 6-Methylmercaptopurine in Whole-Blood by LC/MSMS Using Isotope-Labeled Internal Standards. Therapeutic Drug Monitoring 2013; 35(3): 313 doi: 10.1097/FTD.0b013e318283ed5d
|
51 |
Si Min Zhang, Matthieu Desroses, Anna Hagenkort, Nicholas C. K. Valerie, Daniel Rehling, Megan Carter, Olov Wallner, Tobias Koolmeister, Adam Throup, Ann-Sofie Jemth, Ingrid Almlöf, Olga Loseva, Thomas Lundbäck, Hanna Axelsson, Shruti Regmi, Antonio Sarno, Andreas Krämer, Linda Pudelko, Lars Bräutigam, Azita Rasti, Mona Göttmann, Elisée Wiita, Juliane Kutzner, Torsten Schaller, Christina Kalderén, Armando Cázares-Körner, Brent D. G. Page, Rosa Krimpenfort, Saeed Eshtad, Mikael Altun, Sean G. Rudd, Stefan Knapp, Martin Scobie, Evert J. Homan, Ulrika Warpman Berglund, Pål Stenmark, Thomas Helleday. Development of a chemical probe against NUDT15. Nature Chemical Biology 2020; 16(10): 1120 doi: 10.1038/s41589-020-0592-z
|
52 |
Misbah Misdaq, Reiner Andag, Michael Oellerich, Abdul R. Asif, Nicolas von Ahsen. Establishment of Thiopurine S-Methyltransferase Gene Knockdown in Jurkat T-lymphocytes. Therapeutic Drug Monitoring 2012; 34(5): 584 doi: 10.1097/FTD.0b013e31826ec4b4
|
53 |
Rachele Ciccocioppo, Francesca Racca, Stefania Paolucci, Giulia Campanini, Lodovica Pozzi, Elena Betti, Roberta Riboni, Alessandro Vanoli, Fausto Baldanti, Gino Roberto Corazza. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: Need for mucosal viral load measurement. World Journal of Gastroenterology 2015; 21(6): 1915-1926 doi: 10.3748/wjg.v21.i6.1915
|
54 |
Aaliya Liyakath Ali, Namrata Nailwal, Sujata Sawarkar, Gaurav Doshi. Natural Immunomodulators: Promising Therapy for Disease Management. 2023; : 243 doi: 10.2174/9789815123258123010011
|
55 |
Richard Myles Turner, Munir Pirmohamed. Preventive and Predictive Genetics: Towards Personalised Medicine. Advances in Predictive, Preventive and Personalised Medicine 2015; 9: 109 doi: 10.1007/978-3-319-15344-5_6
|
56 |
Rohan V Yewale, Balakrishnan S Ramakrishna, Babu Vinish Doraisamy, Pandurangan Basumani, Jayanthi Venkataraman, Kayalvizhi Jayaraman, Ananthavadivelu Murali, Karunakaran Premkumar, Akkim Sathish Kumar. Long‐term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real‐world experience. JGH Open 2023; 7(9): 599 doi: 10.1002/jgh3.12955
|
57 |
Jingtao Chen, Patrick Brady, Yasser Saloum, Shanil Lara. 6-Mercaptopurine-Induced Hepatotoxicity During the Treatment of Ulcerative Colitis. Gastroenterology Nursing 2015; 38(1): 65 doi: 10.1097/SGA.0000000000000091
|
58 |
|
59 |
Garth R. Swanson, Mary Biglin, Hannah Raff, Vijit Chouhan, Sarah Jochum, Maliha Shaikh, Lauren Francey, Faraz Bishehsari, John Hogenesch, Ali Keshavarzian. Impact of Chronotherapy on 6-Mercaptopurine Metabolites in Inflammatory Bowel Disease: A Pilot Crossover Trial. Clinical and Translational Gastroenterology 2023; 14(2): e00549 doi: 10.14309/ctg.0000000000000549
|
60 |
Lucy Croyle, Alberta Hoi, Eric F Morand. Characteristics of azathioprine use and cessation in a longitudinal lupus cohort. Lupus Science & Medicine 2015; 2(1): e000105 doi: 10.1136/lupus-2015-000105
|
61 |
Nicole M. Giamanco, Bethany S. Cunningham, Laura S. Klein, Dina S. Parekh, Anne B. Warwick, Kenneth Lieuw. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity. Journal of Pediatric Hematology/Oncology 2016; 38(2): 147 doi: 10.1097/MPH.0000000000000499
|
62 |
Kar Mun Chong, He Jiang, Elaine Ah Gi Lo, Wei-Zhen Hong, Emmett Tsz-Yeung Wong, Gek Cher Chan, Jiacai Cho. Therapeutic Drug Monitoring in Patients with Systemic Lupus Erythematosus: Utility and Gaps. Journal of Clinical Medicine 2024; 13(2): 451 doi: 10.3390/jcm13020451
|
63 |
Lucia Cococcioni, Licia Pensabene, Maria Giovanna Puoti, Sara El-Kouly, Sibongile Chadokufa, Raechel Buckingham, Edward Gaynor, Efstratios Saliakellis, Fevronia Kiparissi, Osvaldo Borrelli. Safety and Efficacy of Split-Dose Thiopurine vs Low-Dose Thiopurine-Allopurinol Cotherapy in Pediatric Inflammatory Bowel Disease. Clinical and Translational Gastroenterology 2023; 14(3): e00544 doi: 10.14309/ctg.0000000000000544
|
64 |
Sheng Zhang Lim, Eng Wee Chua. Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01107
|
65 |
Allison Bigeh, Alexandra Sanchez, Camila Maestas, Martha Gulati. Inflammatory bowel disease and the risk for cardiovascular disease: Does all inflammation lead to heart disease?. Trends in Cardiovascular Medicine 2020; 30(8): 463 doi: 10.1016/j.tcm.2019.10.001
|
66 |
Ali ATAY, Yasemin ÖZDERİN ÖZİN, Dilara TURAN GÖKÇE, Müge BÜYÜKAKSOY, Gamze DEMİREL, Meral AKDOĞAN KAYHAN, Zeki Mesut Yalın KILIÇ, Emin ALTIPARMAK. İnflamatuvar bağırsak hastalığı olan hastalarda immünmodülatör tedaviler güvenli mi? 23 yıllık tek merkez deneyimi. Akademik Gastroenteroloji Dergisi 2023; 22(3): 142 doi: 10.17941/agd.1405423
|